Tag Archives: Turkey

Emerging Markets: Looking Beyond the Heady Growth Numbers

By William Looney | Published: April 27, 2011
A sweet helping of “Turkish delight” for local generic producers amounts to harsh medicine for foreign innovator firms… Emerging markets remain the ace in the card deck for big pharma seeking alternatives to the global slowdown in demand for medicines.  The “pharmerging 17” are dealing a strong hand, with a consensus for continued double-digit growth [...]
Posted in Emerging Markets, Europe, Global, R&D | Also tagged , , | Leave a comment

'Freedom of Thought' Key to Middle East Science Progress

By Jennifer Ringler | Published: March 9, 2011
A new report from Thomson Reuters points to a “rapidly changing context for science and innovation in the Middle East.” The Arabian, Persian and Turkish Middle East may currently produce only 4% of the world’s scientific literature, but the output is growing rapidly, according to a new Global Research Report from Thomson Reuters. Indeed, countries such [...]
Posted in Emerging Markets, Global | Also tagged , , , , , , | Leave a comment

US and Europe At Risk from Substandard Medicines

By Julian Upton | Published: February 25, 2010
Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank. When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to actually [...]
Posted in Biotech, Emerging Markets, Europe, Global, Guest Blog, Regulatory, Safety | Also tagged , , , , , , , , , , | Leave a comment